glp 1 for perimenopause GLP-1 medications are rapidly expanding beyond their role in diabetes and obesity management, with emerging evidence pointing to potential benefits in cardiovascular health, inflammation, neuroprotection, addiction, and more. Join us a Starting a GLP-1 in Perimenopause

The authors wish to express their gratitude to Ing

The authors of this meta-analysis in BPAD suggested that mood state may affect the cerebral GSH content, given similar effects seen with other antioxidant enzymes (Andreazza et al

Research also highlights protective roles in preclinical systems, supporting cellular integrity and recovery processes

It helps to neutralize free radicals, which are unstable molecules that can damage our DNA and lead to chronic diseases like cancer, diabetes, and heart disease

For participants receiving oral semaglutide, the dose was initiated at 3 mg and was escalated to 7 mg and then 14 mg, which was maintained until the end of the trial